Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial.

Cedric BosteelsBastiaan MaesKarel Van DammeElisabeth De LeeuwJozefien DeclercqAnja DelporteBénédicte DemeyereStéfanie VermeerschMarnik VuylstekeJoren WillaertLaura BolléYuri VanbiervlietJana DecuypereFrederick LibeerStefaan VandecasteeleIsabelle PeeneBart Lambrecht

Published in: Trials (2020)

The full protocol is attached as an additional file, accessible from the Trials website (Additional file 1). In the interest in expediting dissemination of this material, the familiar formatting has been eliminated; this Letter serves as a summary of the key elements of the full protocol.

Keyphrases

respiratory failure
randomized controlled trial
coronavirus disease
extracorporeal membrane oxygenation
sars cov
mechanical ventilation
intensive care unit